Celebrations begin!
taurx is reporting that they had a positive result for Lucidity!!!
https://taurx.com/news-insights/initial ... dity-study
"Tau-targeting Alzheimer’s treatment, HMTM, moving toward regulatory submission based on initial data from TauRx’s LUCIDITY trial
• LUCIDITY data suggest that participants receiving hydromethylthionine mesylate (HMTM) decline at a rate substantially less than is typical in Alzheimer’s based on published research
• Safety profile is favourable and consistent with previous HMTM studies
• TauRx will now pursue regulatory submission and coverage for HMTM
Aberdeen, UK and Singapore, May 31, 2022 – TauRx Pharmaceuticals Ltd, the global leader in tau-based research in Alzheimer’s, today announced unblinding of initial data from completion of the randomised portion of their pivotal Phase 3 clinical trial, LUCIDITY (NCT03446001). ..."
Quantification was not provided, though this will be reported on June 9th.